Literature DB >> 27086351

The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.

Emi Takamatsu-Ichihara1, Issay Kitabayashi2.   

Abstract

Polycomb group (PcG) proteins are epigenetic regulatory factors that maintain the repression of target gene expression through histone modification. PcG proteins control the repression of genes that regulate differentiation and the cell cycle in the maintenance of hematopoietic stem cells (HSC). Moreover, abnormalities in expression level and mutations in PcG genes have been reported in various types of cancer, including hematological malignancies. In this review, we present an overview of the roles of PcG proteins in HSC and various types of hematological malignancies.

Entities:  

Keywords:  Leukemia; Polycomb group proteins; Stem cells; Transcription repression

Mesh:

Substances:

Year:  2016        PMID: 27086351     DOI: 10.1007/s12185-016-2011-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  93 in total

1.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.

Authors:  Christopher J Sneeringer; Margaret Porter Scott; Kevin W Kuntz; Sarah K Knutson; Roy M Pollock; Victoria M Richon; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 2.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

3.  Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1.

Authors:  Hideyuki Oguro; Jin Yuan; Hitoshi Ichikawa; Tomokatsu Ikawa; Satoshi Yamazaki; Hiroshi Kawamoto; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  Cell Stem Cell       Date:  2010-03-05       Impact factor: 24.633

4.  Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

Authors:  Isabel Hidalgo; Antonio Herrera-Merchan; Jose Manuel Ligos; Laura Carramolino; Javier Nuñez; Fernando Martinez; Orlando Dominguez; Miguel Torres; Susana Gonzalez
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

5.  Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.

Authors:  Feng Xu; Xiao Li; Lingyun Wu; Qingxia Zhang; Rui Yang; Yujuan Yang; Zheng Zhang; Qi He; Chunkang Chang
Journal:  Ann Hematol       Date:  2010-12-02       Impact factor: 3.673

6.  Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells.

Authors:  Julie K Stock; Sara Giadrossi; Miguel Casanova; Emily Brookes; Miguel Vidal; Haruhiko Koseki; Neil Brockdorff; Amanda G Fisher; Ana Pombo
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

Review 7.  Epigenetics and cancer.

Authors:  Anders H Lund; Maarten van Lohuizen
Journal:  Genes Dev       Date:  2004-10-01       Impact factor: 11.361

8.  The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.

Authors:  Mohamad Mohty; Agnes S M Yong; Richard M Szydlo; Jane F Apperley; Junia V Melo
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

9.  Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

Authors:  Kairong Cui; Chongzhi Zang; Tae-Young Roh; Dustin E Schones; Richard W Childs; Weiqun Peng; Keji Zhao
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

10.  RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3.

Authors:  Lígia Tavares; Emilia Dimitrova; David Oxley; Judith Webster; Raymond Poot; Jeroen Demmers; Karel Bezstarosti; Stephen Taylor; Hiroki Ura; Hiroshi Koide; Anton Wutz; Miguel Vidal; Sarah Elderkin; Neil Brockdorff
Journal:  Cell       Date:  2012-02-09       Impact factor: 41.582

View more
  15 in total

Review 1.  Emerging EZH2 Inhibitors and Their Application in Lymphoma.

Authors:  Jennifer K Lue; Jennifer E Amengual
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 2.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

3.  Guest editorial: Cooperative networks for stem cell homeostasis in normal and malignant hematopoiesis: from metabolism to epigenetics.

Authors:  Atsushi Hirao
Journal:  Int J Hematol       Date:  2016-04-19       Impact factor: 2.490

Review 4.  Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.

Authors:  Goro Sashida; Atsushi Iwama
Journal:  Int J Hematol       Date:  2016-11-09       Impact factor: 2.490

5.  High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis.

Authors:  K C Kawabata; Y Hayashi; D Inoue; H Meguro; H Sakurai; T Fukuyama; Y Tanaka; S Asada; T Fukushima; R Nagase; R Takeda; Y Harada; J Kitaura; S Goyama; H Harada; H Aburatani; T Kitamura
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

6.  Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.

Authors:  Daisuke Honma; Osamu Kanno; Jun Watanabe; Junzo Kinoshita; Makoto Hirasawa; Emi Nosaka; Machiko Shiroishi; Takeshi Takizawa; Isao Yasumatsu; Takao Horiuchi; Akira Nakao; Keisuke Suzuki; Tomonori Yamasaki; Katsuyoshi Nakajima; Miho Hayakawa; Takanori Yamazaki; Ajay Singh Yadav; Nobuaki Adachi
Journal:  Cancer Sci       Date:  2017-08-08       Impact factor: 6.716

7.  MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells.

Authors:  Pei-Pei Liu; Gang-Bin Tang; Ya-Jie Xu; Yu-Qiang Zeng; Shuang-Feng Zhang; Hong-Zhen Du; Zhao-Qian Teng; Chang-Mei Liu
Journal:  Stem Cell Reports       Date:  2017-06-08       Impact factor: 7.765

Review 8.  Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.

Authors:  Sheraz Khan; Mazhar Iqbal; Muhammad Tariq; Shahid M Baig; Wasim Abbas
Journal:  Clin Epigenetics       Date:  2018-02-05       Impact factor: 6.551

Review 9.  Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.

Authors:  Susumu Goyama; Toshio Kitamura
Journal:  Cancer Sci       Date:  2017-04-20       Impact factor: 6.716

10.  Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.

Authors:  Anna Palau; Anne-Kathrin Garz; Jeannine Diesch; Anabel Zwick; Roberto Malinverni; Vanesa Valero; Katrina Lappin; Raquel Casquero; Andreas Lennartsson; Johannes Zuber; Tomàs Navarro; Ken I Mills; Katharina S Götze; Marcus Buschbeck
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.